QUALITY OF LIFE FOR CHILDREN WITH GROWTH HORMONE DEFICIENCY: SIGNIFICANCE OF CLINICAL, PSYCHOEMOTIONAL AND SOCIO-DEMOGRAPHIC FACTORS

Authors

DOI:

https://doi.org/10.21856/j-PEP.2021.3.01

Keywords:

growth hormone deficiency, quality of life, psycho-emotional problems, children

Abstract

The work is devoted to assessing the quality of life (QоL) of children with growth hormone deficiency (GHD)  and  determining the correlation between the QoL and clinical, psycho-emotional and socio-demographic factors. A prospective observational cohort study was carried out at the «Odessa Regional Children's Clinical Hospital» among 46 prepubertal children with GHD and 80 healthy children matched for sex and age. The QоL was determined using Peds QL4.0 questionnaires, which were completed by children and their parents. Total psycho-emotional problems, internalizing and externalizing problems were investigated using 2-factor model of the «Strengths and Difficulties Questionaire (SDQ)», which was completed by the child's parents. The indices of the Peds QL4.0 and SDQ scale were fixed at baseline (T0) and after 12 months (T12) therapy with recombinant human growth hormone (rHGH) at an average dose of 0.033 mg/kg/day. The difference between the observed means ± SD in two independent samples were assessed using t-tests and «p» values. The relationship between clinical, psychological, socio-demographic factors and QoL of children with GHD was assessed by the calculation of Spearman’s correlation coefficient (rs).It was found that GHD was the cause for the decrease in the QoL
according to the «total score» of the Peds QL4.0 scale for children and acccording to the subscales «physical health», «psychosocial health», «emotional functioning», «social functioning», «school functioning». The overall assessment in the SDQ «total difficulties» score increased and the conceptualization of internalizing problems occurred in children with GHD. The 12-months rHGH therapy contributes to the improvement of QoL in children with GHD, the normalization of the psycho-emotional state and the decrease in SDQ «total difficulties» and in «internalizing problems» scores.

References

González Briceño LG, Viaud M, Beltrand J, et al. J Clin Endocrinol Metab 2019; 104(6): 2103-2111. https:// doi.org/10.1210/jc.2018-02523.

Bloemeke J, Silva N, Bullinger M, et al. Health Qual Life Outcomes 2 019; 1 7(1): 4 9. h ttps://doi.org/10.1186/s12955-019-1118-9.

Butler G, Turlejski T, Wales G, et al. Clin Endocrinol (Oxf) 2019; 91(2): 304-313. https://doi.org/10.1111/cen.14011.

Quitmann J, Bloemeke J, Dörr HG, et al. J Endocrinol Invest 2019; 42: 1067-1076. https://doi.org/10.1007/s40618-019-01027-4.

Varni JW, Limbers CA, Burwinkle TM. Health Qua Life Outcomes 2 007; 5: 4 3. https://doi.org/10.1186/1477-7525-5-43.

Goodman R. J Child Psychol Psychiatry 1997; 38(5): 581-586. https://doi.org/10.1111/j.1469-7610.1997.tb01545.x.

Caci H, Morin AJ, Tran A. Eur Child Adolescent Psychiatry 2015; 24: 1291-1301.

Douglas GA. Practical Statistics for Medical Research, London, 2018: 611 р.

Quitmann J, Rohenkohl A, Sommer R, et al. Health Qual Life Outcomes 2 016; 14(1): 1 50. h ttps://doi.org/10.1186/s12955-016-0553-0.

Campbell KA, Gamarra E, Frost CJ, et al. Pediatrics 2020; 146(4): e20200638. https://doi.org/10.1542/peds.2020-0638.

Wu HH, Li H, Gao Q. Health Qual Life Outcomes 2013; 30(11): 87. https://doi.org/10.1186/1477-7525-11-87.

Tanaka T, Hasegawa T, Ozono K, et al. Clin Pediatr Endocrinol 2014; 23(3): 83-92. https://doi.org/10.1297/cpe.23.83.

Geisler A, Lass N, Reinsch N, et al. Horm Res Paediatr 2012; 78(2): 94-99. https://doi.org/10.1159/000341151.

Downloads

Published

2021-09-14

How to Cite

Aryayev, M., & Senkivska, L. (2021). QUALITY OF LIFE FOR CHILDREN WITH GROWTH HORMONE DEFICIENCY: SIGNIFICANCE OF CLINICAL, PSYCHOEMOTIONAL AND SOCIO-DEMOGRAPHIC FACTORS. Problems of Endocrine Pathology, 77(3), 7-13. https://doi.org/10.21856/j-PEP.2021.3.01

Issue

Section

CLINICAL ENDOCRINOLOGY